Skip to main content
. 2020 Sep 29;20:295. doi: 10.1186/s12906-020-03084-2

Table 2.

Comparison of the mean rank of symptoms and intensity of complaints assessed by the Premenstrual Symptoms Screening Tool (PSST) in the Echium amoenum and placebo groups before and during the first and second cycle of intervention

PSST components Placebo group n = 32
Mean rank
Echium amoenum group n = 37
Mean rank
**P-value
Base line 1st cycle of intervention 2st cycle of intervention *P-value Base line 1st cycle of intervention Second month *P-value
Symptoms
 1-Anger/irritability 42.4 40.6 39.5 0.07 46.8 36.7 24.6 < 0.001 < 0.001
 2-Anxiety/tension 32.5 31.4 29.2 0.3 42.8 30.9 18.7 < 0.001 < 0.001
 3-Tearful 33.2 30.0 29.8 0.3 42.6 31.5 18.6 < 0.001 < 0.001
 4-Depressed mood 29.6 31.1 28.4 0.2 43.4 34.8 22.6 < 0.001 < 0.001
 5-Decreased interest in work activities 29.5 25.9 25.0 0.1 39.8 28.8 20.2 < 0.001 < 0.001
 6-Decreased interest in home activities 27.3 25.7 24.8 0.5 37.1 26.1 16.0 < 0.001 < 0.001
 7-Decreased interest in social activities 26.7 23.1 21.9 0.2 40.3 27.8 19.0 < 0.001 < 0.001
 8-Difficulty concentrating 36.4 34.3 32.8 0.1 34.7 30.4 22.3 < 0.001 0.03
 9-Fatigue/lack of energy 37.7 35.4 32.9 0.1 43.2 31.8 20.2 < 0.001 < 0.001
 10-Overeating/food cravings 20.4 18.8 18.6 0.6 27.3 24.4 16.9 < 0.001 0.005
 11-Insomnia 15.3 12.5 14.7 0.7 24.1 18.4 13.7 0.002 0.04
 12-Hypersomnia 31.1 29.1 26.9 0.1 35.4 21.4 17.9 < 0.001 < 0.001
 13-Feeling overwhelmed 31.2 30.1 27.6 0.2 40.0 26.9 18.3 < 0.001 < 0.001
 14-Physical symptoms 39.3 36.1 33.8 0.1 44.2 31.0 22.6 < 0.001 < 0.001
Interference with < 0.001
 15-work efficiency or productivity 33.2 29.5 26.8 0.09 40.8 30.2 19.8 < 0.001 < 0.001
 16-relationships with coworkers 33.3 29.8 28.2 0.2 40.0 29.7 19.0 < 0.001 < 0.001
 17-relationships with family 34.9 31.8 31.0 0.1 36.0 27.7 22.1 < 0.001 0.02
 18-social life activities 28.8 25.1 26.1 0.2 37.2 29.6 25.4 < 0.001 0.02
 19-home responsibilities 25.2 23.7 23.2 0.3 35.9 24.4 20.8 < 0.001 0.003
 Total 31.0 29.4 28.3 0.09 35.3 24.2 16.1 < 0.001 < 0.001

*Within group P-value using Friedman test

**Between groups P-value using Mann-Withney test to compare the differences (baseline score-2nd follow up score) between two study groups

P-value < 0.05 considered statistically significant